Literature DB >> 8325453

Characterization of insulin autoantibodies in relatives of patients with type I diabetes.

L Castaño1, A G Ziegler, R Ziegler, S Shoelson, G S Eisenbarth.   

Abstract

We studied in detail the anti-insulin autoantibodies in 29 nondiabetic relatives of patients with type I diabetes. The affinity of the autoantibodies for [125I]human insulin was high (1.34 x 10(9)-20.71 x 10(9) L/mol), and the capacity was low (0.84 x 10(-12)-37.80 x 10(-12) M). The product of affinity x capacity of each relative's antibodies directly correlated (r = 0.99) with the level of antibodies determined in our standard radioassay. The autoantibodies from each of the subjects studied had the same rank order of affinities for insulin from different species. Guinea pig, fish insulin, and insulin containing Trp rather than Leu in position 13 of the A-chain inhibited minimally the human insulin binding. Human proinsulin, insulin containing Gln rather than Glu in position 17 of the A-chain, and desoctapeptide insulin (des B23-30) all inhibited binding effectively. Insulin autoantibodies in relatives of patients with type I diabetes share common epitope(s), which suggests a common pathogenic mechanism for production of such antibodies. The epitopes from this initial analysis appear to include amino acids B1-B3 and A8-A13. The region recognized can be distinguished from the insulin receptor binding domain.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8325453     DOI: 10.2337/diab.42.8.1202

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  19 in total

Review 1.  Treg vaccination with a strong-agonistic insulin mimetope.

Authors:  Benno Weigmann; Carolin Daniel
Journal:  Curr Diab Rep       Date:  2012-10       Impact factor: 4.810

2.  Longitudinal epitope analysis of insulin-binding antibodies in type 1 diabetes.

Authors:  T R Hall; J W Thomas; C J Padoa; C Torn; M Landin-Olsson; E Ortqvist; C S Hampe
Journal:  Clin Exp Immunol       Date:  2006-10       Impact factor: 4.330

Review 3.  Autoantigens in type 1 diabetes mellitus.

Authors:  F Dotta; E Anastasi; C Tiberti; U Di Mario
Journal:  J Endocrinol Invest       Date:  1994 Jul-Aug       Impact factor: 4.256

4.  Epitope analysis of insulin autoantibodies using recombinant Fab.

Authors:  C J Padoa; N J Crowther; J W Thomas; T R Hall; L M Bekris; C Torn; M Landin-Olsson; E Ortqvist; J P Palmer; A Lernmark; C S Hampe
Journal:  Clin Exp Immunol       Date:  2005-06       Impact factor: 4.330

5.  Mature high-affinity immune responses to (pro)insulin anticipate the autoimmune cascade that leads to type 1 diabetes.

Authors:  Peter Achenbach; Kerstin Koczwara; Annette Knopff; Heike Naserke; Anette-G Ziegler; Ezio Bonifacio
Journal:  J Clin Invest       Date:  2004-08       Impact factor: 14.808

6.  The use of phage display to distinguish insulin autoantibody (IAA) from insulin antibody (IA) idiotypes.

Authors:  D Devendra; T S Galloway; S J Horton; A Evenden; U Keller; T J Wilkin
Journal:  Diabetologia       Date:  2003-06-03       Impact factor: 10.122

7.  Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23).

Authors:  D Daniel; D R Wegmann
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-23       Impact factor: 11.205

Review 8.  Immunotherapy in autoimmune type 1 diabetes.

Authors:  Benno Weigmann; Randi K Franke; Carolin Daniel
Journal:  Rev Diabet Stud       Date:  2012-11-15

9.  Murine high specificity/sensitivity competitive europium insulin autoantibody assay.

Authors:  Naru Babaya; Edwin Liu; Dongmei Miao; Marcella Li; Liping Yu; George S Eisenbarth
Journal:  Diabetes Technol Ther       Date:  2009-04       Impact factor: 6.118

10.  Etiopathogenesis of type 1 diabetes mellitus: prognostic factors for the evolution of residual beta cell function.

Authors:  Sergio A Dib; Marilia B Gomes
Journal:  Diabetol Metab Syndr       Date:  2009-12-04       Impact factor: 3.320

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.